# Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

> **NCT00002693** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic**

## Conditions studied

- Leukemia
- Neutropenia

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00002693
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-10
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** — (—)
- **Last updated:** 2011-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002693, "Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*